Cargando…

Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II-induced hepatic stellate cells activation

The renin angiotensin system (RAS) serves an important role in the development of hepatic fibrosis. Therefore, the present study investigated the effect of levistilide A (Lev A) on hepatic fibrosis via regulation of RAS. The effects of Lev A on the proliferation and activation of hepatic stellate ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Shu, Zhao, Wei, Zhao, Zhimin, Cheng, Binbin, Li, Shuang, Liu, Chenghai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411401/ https://www.ncbi.nlm.nih.gov/pubmed/32705207 http://dx.doi.org/10.3892/mmr.2020.11326

Ejemplares similares

Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling
por: Li, Shu, et al.
Publicado: (2012)

Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
por: Yang, Xiao-Mei, et al.
Publicado: (2022)

Effects of Levistilide A on Hemorheology and Endothelial Cell Injury in Rats with Blood Stasis
por: Liu, XiaoTong, et al.
Publicado: (2021)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Apamin suppresses biliary fibrosis and activation of hepatic stellate cells
por: Kim, Jung-Yeon, et al.
Publicado: (2017)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Levistilide A Ameliorates NLRP3 Expression Involving the Syk-p38/JNK Pathway and Peripheral Obliterans in Rats
por: Guo, Huining, et al.
Publicado: (2018)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Aspirin alleviates hepatic fibrosis by suppressing hepatic stellate cells activation via the TLR4/NF-κB pathway
por: Liu, Yan, et al.
Publicado: (2020)

Ivermectin Attenuates CCl(4)-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation
por: Ying, Hanglu, et al.
Publicado: (2022)

A Combination of an Angiotensin II Receptor and a Neprilysin Inhibitor Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation
por: Suzuki, Junya, et al.
Publicado: (2023)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells
por: Wu, Ying, et al.
Publicado: (2023)

Tanshinone IIA alters the transforming growth factor-β1/Smads pathway in angiotensin II-treated rat hepatic stellate cells
por: Wei, Guo-wei, et al.
Publicado: (2020)

Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10
por: Wang, Ya-Hui, et al.
Publicado: (2017)

Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
por: Han, Qiu-Ju, et al.
Publicado: (2021)

Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway
por: Hu, Jinyuan, et al.
Publicado: (2023)

EZH2‐mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis
por: Yang, Yang, et al.
Publicado: (2017)

Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells
por: Wang, Ning, et al.
Publicado: (2016)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Yao medicine Amydrium hainanense suppresses hepatic fibrosis by repressing hepatic stellate cell activation via STAT3 signaling
por: Wu, Bingmin, et al.
Publicado: (2022)

Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
por: KIM, MINA, et al.
Publicado: (2012)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
por: Li, Juan, et al.
Publicado: (2019)

A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis
por: Chen, Haihua, et al.
Publicado: (2019)

MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression
por: Ma, Liping, et al.
Publicado: (2018)

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis
por: Zhao, Xue-Ke, et al.
Publicado: (2017)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Gypenosides Synergistically Reduce the Extracellular Matrix of Hepatic Stellate Cells and Ameliorate Hepatic Fibrosis in Mice
por: Li, Han, et al.
Publicado: (2023)

In vitro reversion of activated primary human hepatic stellate cells
por: El Taghdouini, Adil, et al.
Publicado: (2015)

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
por: Wang, Man, et al.
Publicado: (2022)

Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β(1)/smad as Potential Anti-Hepatic Fibrosis Agents
por: You, Shu-Ping, et al.
Publicado: (2016)

Correction to: A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis
por: Chen, Haihua, et al.
Publicado: (2020)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rp094u77r95s2ktc592bbimehv